Li, Gan-xun
Chang, Rui-zhi
Liu, Tong-tong
Jin, Guan-nan
Lu, Kan
Yong, Tu-ying http://orcid.org/0000-0002-1255-9798
Li, Zifu http://orcid.org/0000-0001-6387-4854
Liu, Ji-hong
Zhang, Bixiang
Zhang, Wan-guang
Ding, Ze-yang http://orcid.org/0000-0001-5826-0970
Article History
Received: 25 March 2023
Revised: 8 January 2024
Accepted: 9 January 2024
First Online: 24 January 2024
Competing interests
: ZD served as a speaker and consultant for Bayer, Eisai, Roche, MSD, Astra-Zeneca, Innovent, Hengrui, and BeiGene. The remaining authors have nothing to disclose.
: All the data used in this study are deidentified and publicly available. Therefore, the Institutional Review Board (IRB) of Tongji Hospital was waived.